Cargando…
Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
INTRODUCTION: VTE‐BLEED is a validated score for identification of patients at increased risk of major bleeding during extended anticoagulation for venous thromboembolism (VTE). It is unknown whether VTE‐BLEED high‐risk patients also have an increased risk for recurrent VTE, which would limit the po...
Autores principales: | Klok, Frederikus A., Presles, Emilie, Tromeur, Cecile, Barco, Stefano, Konstantinides, Stavros V., Sanchez, Olivier, Pernod, Gilles, Raj, Leela, Robin, Philippe, Le Roux, Pierre‐Yves, Hoffman, Clément, Mélac, Solen, Bertoletti, Laurent, Girard, Philippe, Laporte, Silvy, Mismetti, Patrick, Meyer, Guy, Leroyer, Christophe, Couturaud, Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611364/ https://www.ncbi.nlm.nih.gov/pubmed/31294323 http://dx.doi.org/10.1002/rth2.12214 |
Ejemplares similares
-
Predictive value of venous thromboembolism (VTE)‐BLEED to predict major bleeding and other adverse events in a practice‐based cohort of patients with VTE: results of the XALIA study
por: Klok, Frederikus A., et al.
Publicado: (2018) -
Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
por: Kaptein, Fleur H. J., et al.
Publicado: (2022) -
Growth differentiation factor‐15 for prediction of bleeding in cancer patients
por: Mulder, Frits I., et al.
Publicado: (2021) -
Quality of life and functional limitations after pulmonary embolism and its prognostic relevance
por: Keller, Karsten, et al.
Publicado: (2019) -
Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial
por: Couturaud, Francis, et al.
Publicado: (2019)